Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Aprocitentan (Alias: ACT-132577)

Catalog No. T7817 Copy Product Info
Purity: 99.17%
🥰Excellent
Aprocitentan (ACT-132577) is ETA and ETB antagonist .

Aprocitentan

Copy Product Info
🥰Excellent
Catalog No. T7817
Alias ACT-132577

Aprocitentan (ACT-132577) is ETA and ETB antagonist .

Aprocitentan
Cas No. 1103522-45-7
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$53In StockIn Stock
5 mg$118In StockIn Stock
10 mg$178In StockIn Stock
25 mg$328-In Stock
50 mg$463-In Stock
100 mg$690-In Stock
200 mg$933-In Stock
1 mL x 10 mM (in DMSO)$145In StockIn Stock
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.17%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Aprocitentan AI Summary
Aprocitentan is a potent ETA receptor antagonist with an IC50 value of 3.4 nM, showing high affinity and selectivity compared to its lower affinity ETB receptor antagonistic activity, evidenced by an IC50 value of 987.0 nM. It also exhibits antiviral activity, as demonstrated by its ability to inhibit SARS-CoV-2 induced cytotoxicity in Caco-2 cells by -1.01% at a concentration of 10 µM after 48 hours of exposure, and shows 0.0% inhibition in VERO-6 cells under similar conditions. Additionally, the compound inhibits the SARS-CoV-2 3CL-Pro protease by 8.054% at 20 µM. Finally, Aprocitentan demonstrates inhibitory activity against the human HDAC6 enzyme, with inhibition percentages of -2.24% and -3.72% in enzymatic assays using commercial and custom peptide substrates, respectively..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Aprocitentan (ACT-132577) is ETA and ETB antagonist .
Targets&IC50
ETB:5.5 (pA2), ETB:987 nM (IC50) , ETA:3.4 nM (IC50) , ETA:6.7 (pA2)
SynonymsACT-132577
Chemical Properties
Molecular Weight546.19
FormulaC16H14Br2N6O4S
Cas No.1103522-45-7
SmilesNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 65 mg/mL (119.01 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.66 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8309 mL9.1543 mL18.3086 mL91.5432 mL
5 mM0.3662 mL1.8309 mL3.6617 mL18.3086 mL
10 mM0.1831 mL0.9154 mL1.8309 mL9.1543 mL
20 mM0.0915 mL0.4577 mL0.9154 mL4.5772 mL
50 mM0.0366 mL0.1831 mL0.3662 mL1.8309 mL
100 mM0.0183 mL0.0915 mL0.1831 mL0.9154 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Aprocitentan | purchase Aprocitentan | Aprocitentan cost | order Aprocitentan | Aprocitentan chemical structure | Aprocitentan formula | Aprocitentan molecular weight